Peripheral Nerve Injury Market Size to Hit USD 3.59 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Peripheral Nerve Injury Market

5.1. COVID-19 Landscape: Peripheral Nerve Injury Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Peripheral Nerve Injury Market, By Product Type

8.1. Peripheral Nerve Injury Market Revenue and Volume Forecast, by Product Type

8.1.1. Nerve Conduits

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Nerve Protectors / Wraps

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Nerve Connectors

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Nerve Grafts (Autograft, Allograft)

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Biologics (Stem Cells, Growth Factors)

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Others (Neurostimulation devices, scaffold systems)

8.1.6.1. Market Revenue and Volume Forecast

Chapter 9. Global Peripheral Nerve Injury Market, By Surgical Technique

9.1. Peripheral Nerve Injury Market Revenue and Volume Forecast, by Surgical Technique

9.1.1. Direct Nerve Repair

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Nerve Grafting

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Stem Cell Therapy

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Neurostimulation

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Others (Minimally invasive repair)

9.1.5.1. Market Revenue and Volume Forecast

Chapter 10. Global Peripheral Nerve Injury Market, By Application

10.1. Peripheral Nerve Injury Market Revenue and Volume Forecast, by Application

10.1.1. Upper Extremities

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Lower Extremities

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Facial/Other

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Others (Spinal nerve roots)

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global Peripheral Nerve Injury Market, By Treatment Material

11.1. Peripheral Nerve Injury Market Revenue and Volume Forecast, by Treatment Material

11.1.1. Biomaterials (collagen, hydrogels, synthetic polymers)

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Processed Nerve Allografts

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Autografts

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Others (Nanoparticle scaffolds, 3D-printed implants)

11.1.4.1. Market Revenue and Volume Forecast

Chapter 12. Global Peripheral Nerve Injury Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Product Type

12.1.2. Market Revenue and Volume Forecast, by Surgical Technique

12.1.3. Market Revenue and Volume Forecast, by Application

12.1.4. Market Revenue and Volume Forecast, by Treatment Material

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Product Type

12.1.5.2. Market Revenue and Volume Forecast, by Surgical Technique

12.1.5.3. Market Revenue and Volume Forecast, by Application

12.1.5.4. Market Revenue and Volume Forecast, by Treatment Material

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Product Type

12.1.6.2. Market Revenue and Volume Forecast, by Surgical Technique

12.1.6.3. Market Revenue and Volume Forecast, by Application

12.1.6.4. Market Revenue and Volume Forecast, by Treatment Material

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Product Type

12.2.2. Market Revenue and Volume Forecast, by Surgical Technique

12.2.3. Market Revenue and Volume Forecast, by Application

12.2.4. Market Revenue and Volume Forecast, by Treatment Material

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Product Type

12.2.5.2. Market Revenue and Volume Forecast, by Surgical Technique

12.2.5.3. Market Revenue and Volume Forecast, by Application

12.2.5.4. Market Revenue and Volume Forecast, by Treatment Material

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Product Type

12.2.6.2. Market Revenue and Volume Forecast, by Surgical Technique

12.2.6.3. Market Revenue and Volume Forecast, by Application

12.2.6.4. Market Revenue and Volume Forecast, by Treatment Material

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Product Type

12.2.7.2. Market Revenue and Volume Forecast, by Surgical Technique

12.2.7.3. Market Revenue and Volume Forecast, by Application

12.2.7.4. Market Revenue and Volume Forecast, by Treatment Material

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Product Type

12.2.8.2. Market Revenue and Volume Forecast, by Surgical Technique

12.2.8.3. Market Revenue and Volume Forecast, by Application

12.2.8.4. Market Revenue and Volume Forecast, by Treatment Material

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Product Type

12.3.2. Market Revenue and Volume Forecast, by Surgical Technique

12.3.3. Market Revenue and Volume Forecast, by Application

12.3.4. Market Revenue and Volume Forecast, by Treatment Material

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Product Type

12.3.5.2. Market Revenue and Volume Forecast, by Surgical Technique

12.3.5.3. Market Revenue and Volume Forecast, by Application

12.3.5.4. Market Revenue and Volume Forecast, by Treatment Material

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Product Type

12.3.6.2. Market Revenue and Volume Forecast, by Surgical Technique

12.3.6.3. Market Revenue and Volume Forecast, by Application

12.3.6.4. Market Revenue and Volume Forecast, by Treatment Material

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Product Type

12.3.7.2. Market Revenue and Volume Forecast, by Surgical Technique

12.3.7.3. Market Revenue and Volume Forecast, by Application

12.3.7.4. Market Revenue and Volume Forecast, by Treatment Material

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Product Type

12.3.8.2. Market Revenue and Volume Forecast, by Surgical Technique

12.3.8.3. Market Revenue and Volume Forecast, by Application

12.3.8.4. Market Revenue and Volume Forecast, by Treatment Material

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Product Type

12.4.2. Market Revenue and Volume Forecast, by Surgical Technique

12.4.3. Market Revenue and Volume Forecast, by Application

12.4.4. Market Revenue and Volume Forecast, by Treatment Material

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Product Type

12.4.5.2. Market Revenue and Volume Forecast, by Surgical Technique

12.4.5.3. Market Revenue and Volume Forecast, by Application

12.4.5.4. Market Revenue and Volume Forecast, by Treatment Material

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Product Type

12.4.6.2. Market Revenue and Volume Forecast, by Surgical Technique

12.4.6.3. Market Revenue and Volume Forecast, by Application

12.4.6.4. Market Revenue and Volume Forecast, by Treatment Material

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Product Type

12.4.7.2. Market Revenue and Volume Forecast, by Surgical Technique

12.4.7.3. Market Revenue and Volume Forecast, by Application

12.4.7.4. Market Revenue and Volume Forecast, by Treatment Material

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Product Type

12.4.8.2. Market Revenue and Volume Forecast, by Surgical Technique

12.4.8.3. Market Revenue and Volume Forecast, by Application

12.4.8.4. Market Revenue and Volume Forecast, by Treatment Material

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.2. Market Revenue and Volume Forecast, by Surgical Technique

12.5.3. Market Revenue and Volume Forecast, by Application

12.5.4. Market Revenue and Volume Forecast, by Treatment Material

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Product Type

12.5.5.2. Market Revenue and Volume Forecast, by Surgical Technique

12.5.5.3. Market Revenue and Volume Forecast, by Application

12.5.5.4. Market Revenue and Volume Forecast, by Treatment Material

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Product Type

12.5.6.2. Market Revenue and Volume Forecast, by Surgical Technique

12.5.6.3. Market Revenue and Volume Forecast, by Application

12.5.6.4. Market Revenue and Volume Forecast, by Treatment Material

Chapter 13. Company Profiles

13.1. Stryker Corporation

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Baxter International, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Polyganics BV

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Orthocell Ltd

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Integra Lifesciences Corporation

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Auxilium Biotechnologies

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Alafair Biosciences

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Orthocell Ltd

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Cleveland Clinic (research partner)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. University of Oxford (research collaborator)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global peripheral nerve injury market is expected to increase from USD 1.69 billion in 2024 to USD 3.59 billion by 2034.

The peripheral nerve injury market is expected to grow at a compound annual growth rate (CAGR) of around 7.84% from 2025 to 2034.

The major players in the peripheral nerve injury market include AxoGen, Inc., Stryker Corporation, Baxter International, Inc., Integra Lifesciences Corporation, Polyganics BV, Renerva, LLC, Toyobo Co., Ltd., Newrotex, Orthocell Ltd, Medovent, Auxilium Biotechnologies, BioCircuit Technologies, Isto Biologics, Alafair Biosciences, Fibrant, Alafair Biosciences, Orthocell Ltd, Cleveland Clinic (research partner), University of Oxford (research collaborator), and Medtronic (neurostimulation).

The driving factors of the peripheral nerve injury market are the older individuals are more prone to nerve injuries and degenerative disorders, increasing demand for treatments.

North America region will lead the global peripheral nerve injury market during the forecast period 2025 to 2034.